What You Should Know:
– Sun Genomics raises $8.65M in Series A funding to scale direct to consumer personalized probiotic solutions based on whole-genome sequencing diagnostics.
– Flagship product Floré, a microbiome test, and gut probiotics solution utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product that is based on their unique gut profiles.
Sun Genomics, a San Diego, CA-based direct-to-consumer custom probiotics and gut health company, announced it has raised $8.65 million in Series A funding led by Pangaea Ventures with additional investments from Danone Manifesto
Read more Source: hitconsultant.net